政策与人文

订阅

MedSci主页 / 所有栏目 / 政策与人文

图解：国务院部署完善国家基本药物制度

2018-09-05 佚名 中国劳动保障报

药物制度
关注

会议指出，完善国家基本药物制度，是深化医改、强化医疗卫生基本公共服务的重要举措，有利于满足群众基本用药需求。



会议指出，完善国家基本药物制度，是深化医改、强化医疗卫生基本公共服务的重要举措，有利于满足群众基本用药需求。


版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1665468, encodeId=0f68166546818, content=<a href='/topic/show?id=369f421062f' target=_blank style='color:#2F92EE;'>#基本药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42106, encryptionId=369f421062f, topicName=基本药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=861725964512, createdName=ms9203727104890838, createdTime=Fri Jan 04 01:47:00 CST 2019, time=2019-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342955, encodeId=adea34295548, content=了解一下，谢谢分享！, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Wed Sep 05 22:53:30 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342951, encodeId=7136342951b4, content=学习了，谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Wed Sep 05 22:42:45 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342937, encodeId=af7c34293e16, content=越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Wed Sep 05 22:16:06 CST 2018, time=2018-09-05, status=1, ipAttribution=)]
    2019-01-04 ms9203727104890838

    #基本药物#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1665468, encodeId=0f68166546818, content=<a href='/topic/show?id=369f421062f' target=_blank style='color:#2F92EE;'>#基本药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42106, encryptionId=369f421062f, topicName=基本药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=861725964512, createdName=ms9203727104890838, createdTime=Fri Jan 04 01:47:00 CST 2019, time=2019-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342955, encodeId=adea34295548, content=了解一下，谢谢分享！, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Wed Sep 05 22:53:30 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342951, encodeId=7136342951b4, content=学习了，谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Wed Sep 05 22:42:45 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342937, encodeId=af7c34293e16, content=越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Wed Sep 05 22:16:06 CST 2018, time=2018-09-05, status=1, ipAttribution=)]
    2018-09-05 天地飞扬

    了解一下，谢谢分享！

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1665468, encodeId=0f68166546818, content=<a href='/topic/show?id=369f421062f' target=_blank style='color:#2F92EE;'>#基本药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42106, encryptionId=369f421062f, topicName=基本药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=861725964512, createdName=ms9203727104890838, createdTime=Fri Jan 04 01:47:00 CST 2019, time=2019-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342955, encodeId=adea34295548, content=了解一下，谢谢分享！, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Wed Sep 05 22:53:30 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342951, encodeId=7136342951b4, content=学习了，谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Wed Sep 05 22:42:45 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342937, encodeId=af7c34293e16, content=越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Wed Sep 05 22:16:06 CST 2018, time=2018-09-05, status=1, ipAttribution=)]
    2018-09-05 惠映实验室

    学习了，谢谢分享。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1665468, encodeId=0f68166546818, content=<a href='/topic/show?id=369f421062f' target=_blank style='color:#2F92EE;'>#基本药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42106, encryptionId=369f421062f, topicName=基本药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=861725964512, createdName=ms9203727104890838, createdTime=Fri Jan 04 01:47:00 CST 2019, time=2019-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342955, encodeId=adea34295548, content=了解一下，谢谢分享！, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Wed Sep 05 22:53:30 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342951, encodeId=7136342951b4, content=学习了，谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Wed Sep 05 22:42:45 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342937, encodeId=af7c34293e16, content=越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Wed Sep 05 22:16:06 CST 2018, time=2018-09-05, status=1, ipAttribution=)]
    2018-09-05 医者仁心5538

    越来越好

    0

相关资讯

国家基本药物制度面临调整 看病用药将有哪些变化？

据中国之声《新闻纵横》报道。基本药物，是指能够满足基本医疗卫生需求，剂型适宜、保证供应、基层能够配备、国民能够公平获得的药品，主要特征是安全、必需、有效、价廉。基本药物制度关系到一个国家每一位公民的切身利益。日前，《关于进一步完善国家基本药物制度的意见（征求意见稿）》在行业内征求意见，这次制度调整涉及了哪些关注热点？看病用药又将有哪些变化？热点一：能口服的不肌注，能肌注的不输液长期以来，很多人一直